No Data
PALI Palisade Bio
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Palisade Bio Company
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.
News
Palisade Bio(PALI.US) Director Sells US$192 in Common Stocks
$Palisade Bio(PALI.US)$ Director Trenschel Robert J. sold 300 shares of Common Stocks on Sep 14, 2023 at an average price of $0.64 for a total value of $192.Source: Announcement What is statement of c
Palisade Bio(PALI.US) Officer Buys US$9,825 in Common Stocks
$Palisade Bio(PALI.US)$ Officer Finley John David purchased 15,000 shares of Common Stocks on Sep 13, 2023 at an average price of $0.655 for a total value of $9,825.Source: Announcement What is statem
Palisade Bio Announces Closing of $2 Million Registered Direct Offering Priced At Market Under Nasdaq Rules
Carlsbad, CA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is anno
Comments
how long do you have to wait to fly?